EHF and prostate cancer: However, the molecular mechanisms responsible for the EHF-mediated inhibition of the STAT3 pathway in TNBC cells might be different from those in prostate cancer cells because the mRNA level of IL-6 was significantly increased by EHF overexpression in MDA-MB-453 cells (Supplementary Figure S11).